RU2013109361A - Композиция, содержащая глутатионредуктазу и окисленный глутатион, и ее терапевтическое применение - Google Patents
Композиция, содержащая глутатионредуктазу и окисленный глутатион, и ее терапевтическое применение Download PDFInfo
- Publication number
- RU2013109361A RU2013109361A RU2013109361/15A RU2013109361A RU2013109361A RU 2013109361 A RU2013109361 A RU 2013109361A RU 2013109361/15 A RU2013109361/15 A RU 2013109361/15A RU 2013109361 A RU2013109361 A RU 2013109361A RU 2013109361 A RU2013109361 A RU 2013109361A
- Authority
- RU
- Russia
- Prior art keywords
- gssg
- composition
- use according
- virus
- specified
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract 29
- 108010053070 Glutathione Disulfide Proteins 0.000 title claims abstract 15
- YPZRWBKMTBYPTK-BJDJZHNGSA-N glutathione disulfide Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@H](C(=O)NCC(O)=O)CSSC[C@@H](C(=O)NCC(O)=O)NC(=O)CC[C@H](N)C(O)=O YPZRWBKMTBYPTK-BJDJZHNGSA-N 0.000 title claims abstract 12
- 108010063907 Glutathione Reductase Proteins 0.000 title claims abstract 6
- 102100036442 Glutathione reductase, mitochondrial Human genes 0.000 title claims abstract 6
- YPZRWBKMTBYPTK-UHFFFAOYSA-N oxidized gamma-L-glutamyl-L-cysteinylglycine Natural products OC(=O)C(N)CCC(=O)NC(C(=O)NCC(O)=O)CSSCC(C(=O)NCC(O)=O)NC(=O)CCC(N)C(O)=O YPZRWBKMTBYPTK-UHFFFAOYSA-N 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- 230000003612 virological effect Effects 0.000 claims abstract 6
- 201000010099 disease Diseases 0.000 claims abstract 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract 4
- 239000000725 suspension Substances 0.000 claims abstract 4
- 239000000825 pharmaceutical preparation Substances 0.000 claims abstract 3
- 150000003839 salts Chemical class 0.000 claims abstract 3
- 208000035143 Bacterial infection Diseases 0.000 claims abstract 2
- 108090000790 Enzymes Proteins 0.000 claims abstract 2
- 102000004190 Enzymes Human genes 0.000 claims abstract 2
- 108010003533 Viral Envelope Proteins Proteins 0.000 claims abstract 2
- 208000036142 Viral infection Diseases 0.000 claims abstract 2
- 241000700605 Viruses Species 0.000 claims abstract 2
- 208000022362 bacterial infectious disease Diseases 0.000 claims abstract 2
- 230000005779 cell damage Effects 0.000 claims abstract 2
- 208000037887 cell injury Diseases 0.000 claims abstract 2
- 239000003814 drug Substances 0.000 claims abstract 2
- 241001493065 dsRNA viruses Species 0.000 claims abstract 2
- 230000002255 enzymatic effect Effects 0.000 claims abstract 2
- 230000002265 prevention Effects 0.000 claims abstract 2
- 238000003608 radiolysis reaction Methods 0.000 claims abstract 2
- 231100000331 toxic Toxicity 0.000 claims abstract 2
- 230000002588 toxic effect Effects 0.000 claims abstract 2
- 241000712461 unidentified influenza virus Species 0.000 claims abstract 2
- 241001430294 unidentified retrovirus Species 0.000 claims abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract 2
- 238000000034 method Methods 0.000 claims 4
- 241000711549 Hepacivirus C Species 0.000 claims 1
- 241000700721 Hepatitis B virus Species 0.000 claims 1
- 241000701074 Human alphaherpesvirus 2 Species 0.000 claims 1
- 241000709727 Human poliovirus 3 Species 0.000 claims 1
- 241000829100 Macaca mulatta polyomavirus 1 Species 0.000 claims 1
- 241000714177 Murine leukemia virus Species 0.000 claims 1
- 241000580858 Simian-Human immunodeficiency virus Species 0.000 claims 1
- 239000000443 aerosol Substances 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000006196 drop Substances 0.000 claims 1
- 238000007918 intramuscular administration Methods 0.000 claims 1
- 238000001990 intravenous administration Methods 0.000 claims 1
- 210000004779 membrane envelope Anatomy 0.000 claims 1
- 238000002156 mixing Methods 0.000 claims 1
- 239000002674 ointment Substances 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 239000000243 solution Substances 0.000 claims 1
- 238000003756 stirring Methods 0.000 claims 1
- 238000007920 subcutaneous administration Methods 0.000 claims 1
- 239000000829 suppository Substances 0.000 claims 1
- 239000000522 vaginal cream Substances 0.000 claims 1
- 239000006216 vaginal suppository Substances 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
- A61K38/063—Glutathione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/44—Oxidoreductases (1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y108/00—Oxidoreductases acting on sulfur groups as donors (1.8)
- C12Y108/01—Oxidoreductases acting on sulfur groups as donors (1.8) with NAD+ or NADP+ as acceptor (1.8.1)
- C12Y108/01007—Glutathione-disulfide reductase (1.8.1.7), i.e. glutathione reductase (NADPH)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Toxicology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI2010A001459A IT1401504B1 (it) | 2010-08-02 | 2010-08-02 | Composizione comprendente glutatione reduttasi e glutatione ossidato |
| ITMI2010A001459 | 2010-08-02 | ||
| PCT/IB2011/053390 WO2012017367A1 (fr) | 2010-08-02 | 2011-07-29 | Composition comprenant la glutathion réductase et du glutathion oxydé, et utilisations thérapeutiques de celle-ci |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2013109361A true RU2013109361A (ru) | 2014-09-10 |
Family
ID=43739490
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2013109361/15A RU2013109361A (ru) | 2010-08-02 | 2011-07-29 | Композиция, содержащая глутатионредуктазу и окисленный глутатион, и ее терапевтическое применение |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US8852582B2 (fr) |
| EP (1) | EP2600883A1 (fr) |
| KR (1) | KR20140015246A (fr) |
| CN (1) | CN103167877A (fr) |
| IT (1) | IT1401504B1 (fr) |
| RU (1) | RU2013109361A (fr) |
| WO (1) | WO2012017367A1 (fr) |
Families Citing this family (56)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014070769A1 (fr) * | 2012-10-29 | 2014-05-08 | The University Of North Carolina At Chapel Hill | Méthodes et compositions pour traiter des troubles du tissu mucosal |
| US10163479B2 (en) | 2015-08-14 | 2018-12-25 | Spin Transfer Technologies, Inc. | Method and apparatus for bipolar memory write-verify |
| US10546625B2 (en) | 2016-09-27 | 2020-01-28 | Spin Memory, Inc. | Method of optimizing write voltage based on error buffer occupancy |
| US10437723B2 (en) | 2016-09-27 | 2019-10-08 | Spin Memory, Inc. | Method of flushing the contents of a dynamic redundancy register to a secure storage area during a power down in a memory device |
| US10446210B2 (en) | 2016-09-27 | 2019-10-15 | Spin Memory, Inc. | Memory instruction pipeline with a pre-read stage for a write operation for reducing power consumption in a memory device that uses dynamic redundancy registers |
| US10628316B2 (en) | 2016-09-27 | 2020-04-21 | Spin Memory, Inc. | Memory device with a plurality of memory banks where each memory bank is associated with a corresponding memory instruction pipeline and a dynamic redundancy register |
| US10366774B2 (en) | 2016-09-27 | 2019-07-30 | Spin Memory, Inc. | Device with dynamic redundancy registers |
| US10460781B2 (en) | 2016-09-27 | 2019-10-29 | Spin Memory, Inc. | Memory device with a dual Y-multiplexer structure for performing two simultaneous operations on the same row of a memory bank |
| US11119936B2 (en) | 2016-09-27 | 2021-09-14 | Spin Memory, Inc. | Error cache system with coarse and fine segments for power optimization |
| US10818331B2 (en) | 2016-09-27 | 2020-10-27 | Spin Memory, Inc. | Multi-chip module for MRAM devices with levels of dynamic redundancy registers |
| US10991410B2 (en) | 2016-09-27 | 2021-04-27 | Spin Memory, Inc. | Bi-polar write scheme |
| US11119910B2 (en) | 2016-09-27 | 2021-09-14 | Spin Memory, Inc. | Heuristics for selecting subsegments for entry in and entry out operations in an error cache system with coarse and fine grain segments |
| US10437491B2 (en) | 2016-09-27 | 2019-10-08 | Spin Memory, Inc. | Method of processing incomplete memory operations in a memory device during a power up sequence and a power down sequence using a dynamic redundancy register |
| US10360964B2 (en) | 2016-09-27 | 2019-07-23 | Spin Memory, Inc. | Method of writing contents in memory during a power up sequence using a dynamic redundancy register in a memory device |
| US11151042B2 (en) | 2016-09-27 | 2021-10-19 | Integrated Silicon Solution, (Cayman) Inc. | Error cache segmentation for power reduction |
| MX2019005751A (es) | 2016-11-17 | 2019-11-12 | Renovion Inc | Tratamiento de enfermedades e infecciones de las vias respiratorias con composiciones de acido ascorbico. |
| US10656994B2 (en) | 2017-10-24 | 2020-05-19 | Spin Memory, Inc. | Over-voltage write operation of tunnel magnet-resistance (“TMR”) memory device and correcting failure bits therefrom by using on-the-fly bit failure detection and bit redundancy remapping techniques |
| US10489245B2 (en) | 2017-10-24 | 2019-11-26 | Spin Memory, Inc. | Forcing stuck bits, waterfall bits, shunt bits and low TMR bits to short during testing and using on-the-fly bit failure detection and bit redundancy remapping techniques to correct them |
| US10529439B2 (en) | 2017-10-24 | 2020-01-07 | Spin Memory, Inc. | On-the-fly bit failure detection and bit redundancy remapping techniques to correct for fixed bit defects |
| US10481976B2 (en) | 2017-10-24 | 2019-11-19 | Spin Memory, Inc. | Forcing bits as bad to widen the window between the distributions of acceptable high and low resistive bits thereby lowering the margin and increasing the speed of the sense amplifiers |
| RU2659161C1 (ru) * | 2017-11-17 | 2018-06-28 | Общество С Ограниченной Ответственностью "Ива Фарм" | Фармацевтическая композиция, включающая дисульфид глутатиона и глутатион дисульфид s-оксид |
| LT3710036T (lt) | 2017-11-17 | 2025-01-27 | Renovion, Inc. | Stabilios askorbo rūgšties kompozicijos ir jų naudojimo būdai |
| US10679685B2 (en) | 2017-12-27 | 2020-06-09 | Spin Memory, Inc. | Shared bit line array architecture for magnetoresistive memory |
| US10424726B2 (en) | 2017-12-28 | 2019-09-24 | Spin Memory, Inc. | Process for improving photoresist pillar adhesion during MRAM fabrication |
| US10395711B2 (en) | 2017-12-28 | 2019-08-27 | Spin Memory, Inc. | Perpendicular source and bit lines for an MRAM array |
| US10891997B2 (en) | 2017-12-28 | 2021-01-12 | Spin Memory, Inc. | Memory array with horizontal source line and a virtual source line |
| US10811594B2 (en) | 2017-12-28 | 2020-10-20 | Spin Memory, Inc. | Process for hard mask development for MRAM pillar formation using photolithography |
| US10395712B2 (en) | 2017-12-28 | 2019-08-27 | Spin Memory, Inc. | Memory array with horizontal source line and sacrificial bitline per virtual source |
| US10360962B1 (en) | 2017-12-28 | 2019-07-23 | Spin Memory, Inc. | Memory array with individually trimmable sense amplifiers |
| US10367139B2 (en) | 2017-12-29 | 2019-07-30 | Spin Memory, Inc. | Methods of manufacturing magnetic tunnel junction devices |
| US10546624B2 (en) | 2017-12-29 | 2020-01-28 | Spin Memory, Inc. | Multi-port random access memory |
| US10840436B2 (en) | 2017-12-29 | 2020-11-17 | Spin Memory, Inc. | Perpendicular magnetic anisotropy interface tunnel junction devices and methods of manufacture |
| US10886330B2 (en) | 2017-12-29 | 2021-01-05 | Spin Memory, Inc. | Memory device having overlapping magnetic tunnel junctions in compliance with a reference pitch |
| US10784439B2 (en) | 2017-12-29 | 2020-09-22 | Spin Memory, Inc. | Precessional spin current magnetic tunnel junction devices and methods of manufacture |
| US10424723B2 (en) | 2017-12-29 | 2019-09-24 | Spin Memory, Inc. | Magnetic tunnel junction devices including an optimization layer |
| US10840439B2 (en) | 2017-12-29 | 2020-11-17 | Spin Memory, Inc. | Magnetic tunnel junction (MTJ) fabrication methods and systems |
| US10438995B2 (en) | 2018-01-08 | 2019-10-08 | Spin Memory, Inc. | Devices including magnetic tunnel junctions integrated with selectors |
| US10438996B2 (en) | 2018-01-08 | 2019-10-08 | Spin Memory, Inc. | Methods of fabricating magnetic tunnel junctions integrated with selectors |
| US10446744B2 (en) | 2018-03-08 | 2019-10-15 | Spin Memory, Inc. | Magnetic tunnel junction wafer adaptor used in magnetic annealing furnace and method of using the same |
| US10388861B1 (en) | 2018-03-08 | 2019-08-20 | Spin Memory, Inc. | Magnetic tunnel junction wafer adaptor used in magnetic annealing furnace and method of using the same |
| US11107978B2 (en) | 2018-03-23 | 2021-08-31 | Spin Memory, Inc. | Methods of manufacturing three-dimensional arrays with MTJ devices including a free magnetic trench layer and a planar reference magnetic layer |
| US11107974B2 (en) | 2018-03-23 | 2021-08-31 | Spin Memory, Inc. | Magnetic tunnel junction devices including a free magnetic trench layer and a planar reference magnetic layer |
| US10734573B2 (en) | 2018-03-23 | 2020-08-04 | Spin Memory, Inc. | Three-dimensional arrays with magnetic tunnel junction devices including an annular discontinued free magnetic layer and a planar reference magnetic layer |
| US10784437B2 (en) | 2018-03-23 | 2020-09-22 | Spin Memory, Inc. | Three-dimensional arrays with MTJ devices including a free magnetic trench layer and a planar reference magnetic layer |
| US10411185B1 (en) | 2018-05-30 | 2019-09-10 | Spin Memory, Inc. | Process for creating a high density magnetic tunnel junction array test platform |
| US10559338B2 (en) | 2018-07-06 | 2020-02-11 | Spin Memory, Inc. | Multi-bit cell read-out techniques |
| US10593396B2 (en) | 2018-07-06 | 2020-03-17 | Spin Memory, Inc. | Multi-bit cell read-out techniques for MRAM cells with mixed pinned magnetization orientations |
| US10600478B2 (en) | 2018-07-06 | 2020-03-24 | Spin Memory, Inc. | Multi-bit cell read-out techniques for MRAM cells with mixed pinned magnetization orientations |
| US10692569B2 (en) | 2018-07-06 | 2020-06-23 | Spin Memory, Inc. | Read-out techniques for multi-bit cells |
| US10650875B2 (en) | 2018-08-21 | 2020-05-12 | Spin Memory, Inc. | System for a wide temperature range nonvolatile memory |
| US10699761B2 (en) | 2018-09-18 | 2020-06-30 | Spin Memory, Inc. | Word line decoder memory architecture |
| US10971680B2 (en) | 2018-10-01 | 2021-04-06 | Spin Memory, Inc. | Multi terminal device stack formation methods |
| US11621293B2 (en) | 2018-10-01 | 2023-04-04 | Integrated Silicon Solution, (Cayman) Inc. | Multi terminal device stack systems and methods |
| US11107979B2 (en) | 2018-12-28 | 2021-08-31 | Spin Memory, Inc. | Patterned silicide structures and methods of manufacture |
| US20240139277A1 (en) * | 2020-05-20 | 2024-05-02 | Tohoku University | Drug containing active sulfur compound as its main component |
| KR20240131358A (ko) | 2022-01-04 | 2024-08-30 | 레노비온, 아이엔씨. | 글루타치온 염을 포함하는 수용액 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5281353A (en) * | 1991-04-24 | 1994-01-25 | Allergan, Inc. | Compositions and methods for disinfecting/cleaning of lenses and for destroying oxidative disinfectants |
| US6251857B1 (en) * | 1995-12-14 | 2001-06-26 | Novelos Therapeutics, Inc. | Cytokine and hemopoietic factor endogenous production enhancer and methods of use thereof |
| IT1284139B1 (it) * | 1996-09-06 | 1998-05-08 | Acraf | Composizione farmaceutica comprendente un coenzima utile nel trattamento della sindrome da immunodeficenza acquisita |
| US6013632A (en) * | 1997-01-13 | 2000-01-11 | Emory University | Compounds and their combinations for the treatment of influenza infection |
| IT1312569B1 (it) * | 1999-05-21 | 2002-04-22 | Raffaele Ansovini | Uso dell'enzima gssg reduttasi per il trattamento terapeutico e laprofilassi di pazienti infettati da hiv. |
| CN1253832A (zh) | 1999-12-02 | 2000-05-24 | 石强 | 肝衰代谢支持剂及其制备方法 |
| WO2002062978A1 (fr) | 2001-02-05 | 2002-08-15 | David Holzer | Procede et composition servant a metaboliser in situ glutathione et nad |
| US20030073618A1 (en) * | 2001-02-08 | 2003-04-17 | Kozhemyakin Leonid A. | Compounds comprising disulfide-containing peptides and nitrogenous bases, and medical uses thereof |
| ITMI20010760A1 (it) * | 2001-04-10 | 2002-10-10 | Raffaele Ansovini | Associazione di enzimi coadiuvante nella terapia con interferone |
| US20080221029A1 (en) * | 2002-10-31 | 2008-09-11 | Regents Of The University Of Colorado | Methods for treatment of thiol-containing compound deficient conditions |
| ITTO20031048A1 (it) * | 2003-12-30 | 2005-06-30 | Umberto Benatti | Derivati del glutatione e loro utilizzi per il trattamento di malattie virali. |
| WO2009023355A2 (fr) | 2007-05-25 | 2009-02-19 | Ironwood Pharmaceuticals, Inc. | Compositions et procédés pour réduire la toxicité de certaines toxines |
-
2010
- 2010-08-02 IT ITMI2010A001459A patent/IT1401504B1/it active
-
2011
- 2011-07-29 RU RU2013109361/15A patent/RU2013109361A/ru not_active Application Discontinuation
- 2011-07-29 WO PCT/IB2011/053390 patent/WO2012017367A1/fr not_active Ceased
- 2011-07-29 CN CN2011800383817A patent/CN103167877A/zh active Pending
- 2011-07-29 EP EP11754493.2A patent/EP2600883A1/fr not_active Withdrawn
- 2011-07-29 US US13/813,426 patent/US8852582B2/en not_active Expired - Fee Related
- 2011-07-29 KR KR1020137005587A patent/KR20140015246A/ko not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| CN103167877A (zh) | 2013-06-19 |
| US8852582B2 (en) | 2014-10-07 |
| KR20140015246A (ko) | 2014-02-06 |
| IT1401504B1 (it) | 2013-07-26 |
| EP2600883A1 (fr) | 2013-06-12 |
| ITMI20101459A1 (it) | 2012-02-03 |
| WO2012017367A1 (fr) | 2012-02-09 |
| US20130216514A1 (en) | 2013-08-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2011088561A1 (fr) | Composés antiviraux et compositions | |
| AU2021361059B2 (en) | Phospholipid compounds and uses thereof | |
| UA104021C2 (ru) | ПРОИЗВОДНЫЕ ТИЕНО[2,3-b]ПИРИДИНА КАК ИНГИБИТОРЫ РЕПЛИКАЦИИ ВИРУСА | |
| MX2012007410A (es) | Compuestos antivirales novedosos. | |
| Kononova et al. | N-Heterocyclic borneol derivatives as inhibitors of Marburg virus glycoprotein-mediated VSIV pseudotype entry | |
| NO20064933L (no) | Makrosykliske forbindelser som inhibitorer av viral replikasjon | |
| EA200501680A1 (ru) | Фосфонатсодержащие антивирусные соединения (варианты), фармацевтическая композиция (варианты), способ ее получения (варианты), лекарственная форма на их основе и способы их применения в лечении заболеваний, способы ингибирования вирусного фермента (варианты) и рнк-зависимой рнк полимеразы (варианты) | |
| MA34013B1 (fr) | Inhibiteurs du virus de l'hépatite c | |
| TW200510391A (en) | Inhibitors of serine proteases, particularly HCV NS3-NS4A protease | |
| CA3257287A1 (fr) | Méthodes de traitement d'infections virales y compris le sars-cov-2 | |
| KR20140015246A (ko) | 글루타티온 환원효소 및 산화된 글루타티온을 포함하는 조성물, 및 이의 치료학적 용도 | |
| YU27203A (sh) | Pirazol derivati za tretiranje virusnih oboljenja | |
| US20250109157A1 (en) | Compounds and methods for treatment of viral infections | |
| CA2556829C (fr) | Nucleosides phosphonates utiles en tant que principes actifs dans des compositions pharmaceutiques pour le traitement d'infections virales, et intermediaires pour leur production | |
| US20100168225A1 (en) | Small-Molecule Hepatitis C Virus (HCV) NS3/4A Serine Protease Inhibitors | |
| CN109364074B (zh) | 6-氨基烟酰胺作为有效成分在制备乙型肝炎治疗药物中的用途 | |
| WO2017035127A1 (fr) | Phénylpyrrole-carboxamides substitués présentant une activité thérapeutique contre le vih | |
| ES2764440T3 (es) | Fenilpirrolcarboxamidas sustituidas con actividad terapéutica en VIH | |
| US9084758B2 (en) | Antiviral compositions comprising ethanol extract of Tetracera scandens and use thereof | |
| Pasquinelli et al. | SAFETY, TOLERABILITY, PHARMACOKINETICS AND ANTIVIRAL ACTIVITY FOLLOWING SINGLE-AND MULTIPLE-DOSE ADMINISTRATION OF BMS-650032, A NOVEL HCV NS3 INHIBITOR, IN SUBJECTS WITH CHRONIC GENOTYPE 1 HCV INFECTION: 225 | |
| JPH07188017A (ja) | チアジアゾール誘導体を含有する抗ウイルス剤 | |
| CN114796233A (zh) | 积雪草酸在制备乙型肝炎治疗药物中的用途 | |
| EP4259100A1 (fr) | Matériels et méthodes pour le traitement de pathologies virales et autres pathologies médicales | |
| CN107648249B (zh) | 去半乳糖替告皂甙在制备防治流感病毒感染的药物中的应用 | |
| Khanna et al. | Thiol drugs decrease SARS-CoV-2 lung injury in vivo and disrupt SARS-CoV-2 spike |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20151202 |